{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:00:26Z","timestamp":1781647226707,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013139","name":"Humanities and Social Science Fund of Ministry of Education of China","doi-asserted-by":"publisher","award":["22JJD910001"],"award-info":[{"award-number":["22JJD910001"]}],"id":[{"id":"10.13039\/501100013139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patient-reported outcome (PRO) measures are widely used in clinical trials to capture patients\u2019 perspectives on their health and treatment. However, missing data remains a major challenge and can lead to biased or incomplete results. Understanding how different methods for handling missing data perform under realistic conditions is essential for decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a simulation study informed by a review of 87 PRO instruments, modeling both simple and complex questionnaire structures in a hypothetical randomized trial. Under both the missing at random (MAR) and missing not at random (MNAR) assumptions, four commonly used approaches were evaluated: multiple imputation (MI) at the item level, MI at the total score level, item mean, and mixed model for repeated measurements (MMRM). To make the study more realistic, we also ran simulations using actual trial data from the COU-AA-302 study, focusing on the Functional Assessment of Cancer Therapy\u2013Prostate (FACT-P) questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The simulation results supported the use of the \u201cHalf Rule\u201d under MAR. When the number of missing items did not exceed half of the total items, item mean imputation showed reasonable estimation with low root mean squared error, high power, and low type 1 error. MI on item scores consistently performed well, but inflated type 1 error under certain MNAR scenarios. As the missing visit rate increased, the advantage of item level imputation diminished, i.e., RMSE approached and eventually exceeded that of MI on the total score. In the trial data analysis, given the high missing visit rate in the collected FACT-P data, MI on total score level performed not worse than MI on item score level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No single method is optimal for all situations. Item-level imputation performs well when missing data are minimal and occur at random, but it becomes less reliable when data is missing not at random. For complex PROs or studies with many missing visits, imputing at the total score level with the \u201cHalf Rule\u201d offers a practical alternative. Strategies should match the missingness pattern, supported by simulations and sensitivity analyses to ensure robust results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41687-026-01060-x","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T14:45:15Z","timestamp":1775918715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Missing data considerations for patient reported outcome measures in randomized controlled trials"],"prefix":"10.1186","volume":"10","author":[{"given":"Fan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenran","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine M.","family":"Norquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Golm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W. B.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianzhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1083-9542","authenticated-orcid":false,"given":"Hao","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"1060_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2147\/PROM.S156279","volume":"9","author":"R Mercieca-Bebber","year":"2018","unstructured":"Mercieca-Bebber R et al (2018) The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas 9:353\u2013367","journal-title":"Patient Relat Outcome Meas"},{"key":"1060_CR2","doi-asserted-by":"publisher","first-page":"f167","DOI":"10.1136\/bmj.f167","volume":"346","author":"N Black","year":"2013","unstructured":"Black N (2013) Patient reported outcome measures could help transform healthcare. BMJ 346:f167","journal-title":"BMJ"},{"issue":"12","key":"1060_CR3","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1002\/cam4.3018","volume":"9","author":"M Van Hemelrijck","year":"2020","unstructured":"Van Hemelrijck M et al (2020) Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient-reported outcomes in randomized controlled trials to support clinical decision-making. Cancer Med 9(12):4039\u20134058","journal-title":"Cancer Med"},{"issue":"4","key":"1060_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jval.2020.11.004","volume":"24","author":"JM Giesinger","year":"2021","unstructured":"Giesinger JM et al (2021) Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review. Value Health 24(4):585\u2013591","journal-title":"Value Health"},{"key":"1060_CR5","unstructured":"U. S. Food and Drug Administration. Guidance for industry, patient-reported outcome measures: Use in medical product development to support labeling claims. 2009 [Accessed 2024; Available from: https:\/\/www.fda.gov\/media\/77832\/download"},{"key":"1060_CR6","unstructured":"European Medicines Agency. The use of patient-reported outcome (PRO) measures in oncology studies (2016) [Accessed 2024; Available from: https:\/\/www.ema.europa.eu\/en\/documents\/other\/appendix-2-guideline-evaluation-anticancer-medicinal-products-man_en.pdf"},{"issue":"1","key":"1060_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1477-7525-8-89","volume":"8","author":"LC Doward","year":"2010","unstructured":"Doward LC, Gnanasakthy A, Baker MG (2010) Patient reported outcomes: looking beyond the label claim. Health Qual Life Outcomes 8(1):89","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"1060_CR8","doi-asserted-by":"publisher","first-page":"e010938","DOI":"10.1136\/bmjopen-2015-010938","volume":"6","author":"R Mercieca-Bebber","year":"2016","unstructured":"Mercieca-Bebber R et al (2016) Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review. BMJ Open 6(6):e010938","journal-title":"BMJ Open"},{"issue":"7","key":"1060_CR9","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s11136-015-1206-1","volume":"25","author":"I Rombach","year":"2016","unstructured":"Rombach I et al (2016) The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literature. Qual Life Res 25(7):1613\u20131623","journal-title":"Qual Life Res"},{"key":"1060_CR10","doi-asserted-by":"publisher","first-page":"S227","DOI":"10.1016\/j.jval.2018.04.1539","volume":"21","author":"EK Chan","year":"2018","unstructured":"Chan EK et al (2018) Missing Data in Patient-Reported Outcomes: Regulatory, Statistical, and Operational Perspectives. Value Health 21:S227","journal-title":"Value Health"},{"issue":"5","key":"1060_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/0962280213476378","volume":"23","author":"ML Bell","year":"2014","unstructured":"Bell ML, Fairclough DL (2014) Practical and statistical issues in missing data for longitudinal patient-reported outcomes. Stat Methods Med Res 23(5):440\u2013459","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"1060_CR12","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s11136-014-0837-y","volume":"24","author":"CL Simons","year":"2014","unstructured":"Simons CL et al (2014) Multiple imputation to deal with missing EQ-5D-3L data: Should we impute individual domains or the actual index? Qual Life Res 24(4):805\u2013815","journal-title":"Qual Life Res"},{"issue":"1","key":"1060_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12874-018-0542-6","volume":"18","author":"I Rombach","year":"2018","unstructured":"Rombach I et al (2018) Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level. BMC Med Res Methodol 18(1):87","journal-title":"BMC Med Res Methodol"},{"issue":"17","key":"1060_CR14","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1080\/00949655.2018.1520854","volume":"88","author":"N Nooraee","year":"2018","unstructured":"Nooraee N et al (2018) Strategies for handling missing data in longitudinal studies with questionnaires. J Stat Comput Simul 88(17):3415\u20133436","journal-title":"J Stat Comput Simul"},{"issue":"21","key":"1060_CR15","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1002\/sim.9088","volume":"40","author":"R Mainzer","year":"2021","unstructured":"Mainzer R et al (2021) A comparison of multiple imputation strategies for handling missing data in multi-item scales: Guidance for longitudinal studies. Stat Med 40(21):4660\u20134674","journal-title":"Stat Med"},{"issue":"4","key":"1060_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/10705511.2020.1850289","volume":"28","author":"JD Vera","year":"2021","unstructured":"Vera JD, Enders CK (2021) Is Item Imputation Always Better? An Investigation of Wave-Missing Data in Growth Models. Struct Equation Modeling: Multidisciplinary J 28(4):506\u2013517","journal-title":"Struct Equation Modeling: Multidisciplinary J"},{"issue":"1","key":"1060_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12874-023-01968-8","volume":"23","author":"M Jahangiri","year":"2023","unstructured":"Jahangiri M et al (2023) A wide range of missing imputation approaches in longitudinal data: a simulation study and real data analysis. BMC Med Res Methodol 23(1):161","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"1060_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jclinepi.2013.09.009","volume":"67","author":"I Eekhout","year":"2014","unstructured":"Eekhout I et al (2014) Missing data in a multi-item instrument were best handled by multiple imputation at the item score level. J Clin Epidemiol 67(3):335\u2013342","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1060_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s13104-016-2284-z","volume":"9","author":"ML Bell","year":"2016","unstructured":"Bell ML et al (2016) Handling missing items in the Hospital Anxiety and Depression Scale (HADS): a simulation study. BMC Res Notes 9(1):479","journal-title":"BMC Res Notes"},{"issue":"3","key":"1060_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1037\/met0000584","volume":"30","author":"E Alacam","year":"2025","unstructured":"Alacam E et al (2025) A factored regression model for composite scores with item-level missing data. Psychol Methods 30(3):462\u2013481","journal-title":"Psychol Methods"},{"issue":"5\u20137","key":"1060_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/(SICI)1097-0258(19980315\/15)17:5\/7<679::AID-SIM814>3.0.CO;2-X","volume":"17","author":"PM Fayers","year":"1998","unstructured":"Fayers PM, Curran D, Machin D (1998) Incomplete quality of life data in randomized trials: missing items. Stat Med 17(5\u20137):679\u2013696","journal-title":"Stat Med"},{"key":"1060_CR22","unstructured":"Fairclough DL (2010) Design and analysis of quality of life studies in clinical trials. Chapman and Hall\/CRC"},{"issue":"2","key":"1060_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11136-010-9740-3","volume":"20","author":"H Peyre","year":"2011","unstructured":"Peyre H, Lepl\u00e8ge A, Coste J (2011) Missing data methods for dealing with missing items in quality of life questionnaires. A comparison by simulation of personal mean score, full information maximum likelihood, multiple imputation, and hot deck techniques applied to the SF-36 in the French 2003 decennial health survey. Qual Life Res 20(2):287\u2013300","journal-title":"Qual Life Res"},{"issue":"1","key":"1060_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1037\/adb0000015","volume":"29","author":"MR Lee","year":"2015","unstructured":"Lee MR et al (2015) Two alternative approaches to conventional person-mean imputation scoring of the Self-Rating of the Effects of Alcohol Scale (SRE). Psychol Addict Behav 29(1):231\u2013236","journal-title":"Psychol Addict Behav"},{"issue":"4","key":"1060_CR25","first-page":"682","volume":"8","author":"PH Rezvan","year":"2022","unstructured":"Rezvan PH et al (2022) Assessing Alternative Imputation Strategies for Infrequently Missing Items on Multi-item Scales. Commun Stat Case Stud Data Anal Appl 8(4):682\u2013713","journal-title":"Commun Stat Case Stud Data Anal Appl"},{"key":"1060_CR26","unstructured":"R Core Team (2023) R: a language and environment for statistical computing"},{"key":"1060_CR27","doi-asserted-by":"crossref","unstructured":"Sabanes Bove D et al (2023) mmrm: mixed models for repeated measures.","DOI":"10.32614\/CRAN.package.mmrm"},{"issue":"3","key":"1060_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S (2011) Groothuis-Oudshoorn, mice: Multivariate Imputation by Chained Equations in R. J Stat Softw 45(3):1\u201367","journal-title":"J Stat Softw"},{"issue":"2","key":"1060_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S1470-2045(14)71205-7","volume":"16","author":"CJ Ryan","year":"2015","unstructured":"Ryan CJ et al (2015) Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Lancet Oncol 16(2):152\u2013160","journal-title":"Lancet Oncol"},{"issue":"4","key":"1060_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.12788\/jcso.0246","volume":"14","author":"D Cella","year":"2016","unstructured":"Cella D et al (2016) Repeated measures analysis of patient-reported outcomes in prostate cancer after abiraterone acetate. J Community Supportive Oncol 14(4):148\u2013154","journal-title":"J Community Supportive Oncol"},{"key":"1060_CR31","doi-asserted-by":"crossref","unstructured":"Little RJ, Rubin DB (2019) Statistical analysis with missing data, vol 793. Wiley","DOI":"10.1002\/9781119482260"},{"key":"1060_CR32","doi-asserted-by":"crossref","unstructured":"Muth\u00e9n B et al (2011) Growth modeling with nonignorable dropout: alternative analyses of the STAR* D antidepressant trial. 16(1):17","DOI":"10.1037\/a0022634"},{"issue":"4","key":"1060_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.20982\/tqmp.19.4.p347","volume":"19","author":"JL Peugh","year":"2023","unstructured":"Peugh JL, Toland MD, Harrison H (2023) A tutorial for handling suspected missing not at random data in longitudinal clinical trials. Quant Methods Psychol 19(4):347\u2013367","journal-title":"Quant Methods Psychol"},{"key":"1060_CR34","doi-asserted-by":"crossref","unstructured":"Noghrehchi F et al (2021) Selecting the model for multiple imputation of missing data: Just use an IC! Statistics in Medicine. 40(10):2467\u20132497","DOI":"10.1002\/sim.8915"},{"issue":"3","key":"1060_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/00273171.2014.999267","volume":"50","author":"WJ Howard","year":"2015","unstructured":"Howard WJ, Rhemtulla M, Little TD (2015) Using Principal Components as Auxiliary Variables in Missing Data Estimation. Multivar Behav Res 50(3):285\u2013299","journal-title":"Multivar Behav Res"},{"issue":"4","key":"1060_CR36","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1177\/0962280216654511","volume":"27","author":"I Eekhout","year":"2016","unstructured":"Eekhout I et al (2016) Passive imputation and parcel summaries are both valid to handle missing items in studies with many multi-item scales. Stat Methods Med Res 27(4):1128\u20131140","journal-title":"Stat Methods Med Res"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-026-01060-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-026-01060-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-026-01060-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:51:05Z","timestamp":1781646665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41687-026-01060-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1060"],"URL":"https:\/\/doi.org\/10.1186\/s41687-026-01060-x","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing risk.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}